首页 | 官方网站   微博 | 高级检索  
     

姜黄素联合奥沙利铂对人结肠癌LoVo细胞裸鼠移植瘤的抗癌作用研究
引用本文:郭立达,薛佳伟,渠开跃,赵秀军,滕文华,刘敬泽.姜黄素联合奥沙利铂对人结肠癌LoVo细胞裸鼠移植瘤的抗癌作用研究[J].中草药,2013,44(16):2261-2266.
作者姓名:郭立达  薛佳伟  渠开跃  赵秀军  滕文华  刘敬泽
作者单位:1. 河北工业职业技术学院环境与化学工程系,河北石家庄050091;河北师范大学生命科学学院,河北石家庄050024
2. 河北工业职业技术学院环境与化学工程系,河北石家庄,050091
3. 河北医科大学组胚教研室,河北石家庄,050017
4. 河北师范大学生命科学学院,河北石家庄,050024
基金项目:河北省科技计划项目(JB00 09276160);河北省教育厅自然科学青年基金资助项目(Q2012055);河北工业职业技术学院引进人才科研启动基金资助项目(BZ1201)
摘    要:目的 探讨姜黄素与奥沙利铂联用对人结肠癌LoVo细胞株裸鼠移植瘤生长的影响及其作用机制.方法 将LoVo细胞接种子裸鼠皮下,制备裸鼠移植瘤模型.将造模成功的裸鼠随机分为对照组、姜黄素50 mg/kg组、奥沙利铂25 mg/kg组、姜黄素50 mg/kg+奥沙利铂25 mg/kg联合给药组,给药组裸鼠隔天ip给药1次,连续给药11次.末次给药后剥离瘤块称质量,计算移植瘤体积、抑瘤率;摘除眼球取血,检测血常规及肝、肾功能;流式细胞仪检测肿瘤细胞周期和凋亡率;HE染色分析肿瘤组织病理形态学;RT-PCR检测细胞凋亡相关基因的表达.结果 姜黄素组、奥沙利铂组、联合用药组的抑瘤率分别为59.47%、55.49%、70.56%,联合给药组抑制肿瘤生长的作用显著且对荷瘤裸鼠血液及肝肾无明显毒性;联合给药组可显著阻滞肿瘤细胞于S期和G2/M期,显著上调bax基因的表达.结论 姜黄素联合奥沙利铂可显著抑制LoVo细胞裸鼠移植瘤的生长.

关 键 词:姜黄素  奥沙利铂  联合给药  结肠癌  LoVo裸鼠移植瘤  细胞凋亡

Antitumor effects of curcumin and oxaliplatin combination on xenografts of human colon cancer LoVo cells in nude mice
GUO Li-d,XUE Jia-wei,QU Kai-yue,ZHAO Xiu-jun,TENG Wen-hu,LIU Jing-ze.Antitumor effects of curcumin and oxaliplatin combination on xenografts of human colon cancer LoVo cells in nude mice[J].Chinese Traditional and Herbal Drugs,2013,44(16):2261-2266.
Authors:GUO Li-d  XUE Jia-wei  QU Kai-yue  ZHAO Xiu-jun  TENG Wen-hu  LIU Jing-ze
Affiliation:1.Department of Environment and Chemical Engineering, Hebei College of Industry and Technology, Shijiazhuang 050091, China 2.College of Life Sciences, Hebei Normal University, Shijiazhuang 050024, China 3.Department of Histology and Embryology, Hebei Medical University, Shijiazhuang 050017, China
Abstract:Objective To investigate the effects of curcumin combined with oxaliplatin on the human colon cancer cells LoVo xenografted tumor in nude mice and to explore the mechanism. Methods Nude mice were implanted with human colon cancer LoVo cells. All tumor-bearing mice were randomly divided into four groups and treated with vehicle, 50 mg/kg curcumin, 25 mg/kg oxaliplatin, and their combination (50 mg/kg curcumin + 25 mg/kg oxaliplatin) by ip injection once every other day individually. After continuous administration of drug treatment for 11 times, the weights of nude mice were recorded, the stripping tumor weight was monitored, and the tumor volume and tumor inhibitory rates were calculated. The enucleation of eyeball for taking blood and blood routine examination were carried out and the function of liver and kidney was detected. Tumor cell cycle and apoptosis rate were assayed by flow cytometry. The pathological morphology of tumor was analyzed by HE staining. The apoptosis related gene expression was detected by RT-PCR. Results Tumor inhibitory rates of curcumin, oxaliplatin, and curcumin + oxaliplatin groups were 59.47%, 55.49%, and 70.56%, respectively. Curcumin combination with oxaliplatin did not influence the blood system, liver, and kidneys in nude mice. Combination of curcumin and oxaliplatin could effectively inhibit the tumor growth (P < 0.05), interfere with cell cycle arresting at S and G2/M phases (P < 0.05, 0.01), and promote the expression of bax (P < 0.01) in tumor-bearing nude mice. Conclusion Combination of curcumin and oxaliplatin could synergistically inhibit the growth of LoVo colonic xenografts in nude mice.
Keywords:curcumin  oxaliplatin  combined administration  colon cancer  xenografted tumor in LoVo-bearing nude mice  apoptosis
本文献已被 万方数据 等数据库收录!
点击此处可从《中草药》浏览原始摘要信息
点击此处可从《中草药》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号